A phase II study to evaluate the efficacy, safety, and pharmacodynamics of lapatinib in combination with paclitaxel as neoadjuvant therapy in patients with newly diagnosed inflammatory breast cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Lapatinib; Paclitaxel
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 08 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 23 Jul 2007 Updated status from NCT.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History